DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Cassier PA, Garin G, Eberst L. et al.
MEDIPLEX: a phase 1 study of durvalumab (D) combined with pexidartinib (P) in patients (pts) with advanced pancreatic ductal adenocarcinoma (PDAC) and colorectal cancer (CRC).
J Clin Oncol 2019;
37 (15) 2579
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.